 BrainStorm-Cell Therapeutics Inc. NASDAQ: BCLI, a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2020, and provide a corporate update, at 8:00 a.m., Eastern Daylight Time EDT, on Wednesday, August 5 2020. 